1. A prospective observational safety study of patients with BRAFV600‐mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study). (10th February 2019) Authors: Corrie, P.G.; Terheyden, P.; ten Tije, A.J.; Herbst, R.; Jansen, R.; Marples, M.; Debus, D.; Marconcini, R.; Blasinska‐Morawiec, M.; Freivogel, K.; Munson, M.L.G.; Goodman, G.R.; Hsu, J.J.; Sadetsky, N.; Colburn, D.; Rutkowski, P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A prospective observational safety study of patients with BRAFV600‐mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study). (1st May 2019) Authors: Corrie, P.G.; Terheyden, P.; ten Tije, A.J.; Herbst, R.; Jansen, R.; Marples, M.; Debus, D.; Marconcini, R.; Blasinska‐Morawiec, M.; Freivogel, K.; Munson, M.L.G.; Goodman, G.R.; Hsu, J.J.; Sadetsky, N.; Colburn, D.; Rutkowski, P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0146 Self-Reactive IGE Exacerbates Interferon Responses Associated with Autoimmunity. (15th July 2016) Authors: Sanjuan, M.A.; Henault, J.; Riggs, J.; Karnell, J.L.; Liarski, V.; Shirinian, L.; Xu, L.; Casey, K.; Smith, M.A.; Khatry, D.; Clarke, L.; Herbst, R.; Ettinger, R.; Petri, M.; Clark, M.R.; Mustelin, T.; Kolbeck, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 946 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non–small-cell lung carcinoma. (August 2020) Authors: Boulle, G.; Velut, Y.; Mansuet-Lupo, A.; Gibault, L.; Blons, H.; Fournel, L.; Boni, A.; Cremer, I.; Wislez, M.; Duchatelle, V.; Trédaniel, J.; Hammond, S.A.; Herbst, R.; Alifano, M.; Giraud, P.; Damotte, D. Journal: European journal of cancer Issue: Volume 135(2020) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Design and performance of a 35-ton liquid argon time projection chamber as a prototype for future very large detectors. (31st March 2020) Authors: Adams, D.L.; Baird, M.; Barr, G.; Barros, N.; Blake, A.; Blaufuss, E.; Booth, A.; Brailsford, D.; Buchanan, N.; Carls, B.; Chen, H.; Convery, M.; Geronimo, G. De; Dealtry, T.; Dharmapalan, R.; Djurcic, Z.; Fowler, J.; Glavin, S.; Gomes, R.A.; Goodman, M.C. Journal: Journal of instrumentation Issue: Volume 15:Number 3(2020) Page Start: P03035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real‐world conditions in Germany – The non‐interventional study NIELS. (27th May 2021) Authors: Gutzmer, R.; Schulze, H.‐J.; Hauschild, A.; Leiter, U.; Meier, F.; Haferkamp, S.; Ulrich, C.; Wahl, R.U.; Berking, C.; Herbst, R.; Häckl, M.; Schadendorf, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 8(2021) Page Start: 1678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0482 Safety and Tolerability of MEDI-551 in Subjects with Systemic Sclerosis (SSC): Results from A Phase 1 Randomized, Placebo-Controlled Escalating Single-Dose Study. (10th June 2014) Authors: Schiopu, E.; Chatterjee, S.; Hsu, V.; Flor, A.; Pavlovic, D.; Patra, K.; Li, J.; McKeever, K.; Herbst, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. (13th April 2020) Authors: Livingstone, E.; Zaremba, A.; Horn, S.; Ugurel, S.; Casalini, B.; Schlaak, M.; Hassel, J.C.; Herbst, R.; Utikal, J.S.; Weide, B.; Gutzmer, R.; Meier, F.; Koelsche, C.; Hadaschik, E.; Sucker, A.; Reis, H.; Merkelbach‐Bruse, S.; Siewert, M.; Sahm, F.; von Deimling, A. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. (1st November 2020) Authors: Livingstone, E.; Zaremba, A.; Horn, S.; Ugurel, S.; Casalini, B.; Schlaak, M.; Hassel, J.C.; Herbst, R.; Utikal, J.S.; Weide, B.; Gutzmer, R.; Meier, F.; Koelsche, C.; Hadaschik, E.; Sucker, A.; Reis, H.; Merkelbach‐Bruse, S.; Siewert, M.; Sahm, F.; von Deimling, A. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0303 Mavrilimumab Reduces Pro-Inflammatory Cytokines and CD68 Positive Macrophages in Synovial Explants from Rheumatoid Arthritis Subjects Engrafted Into SCID/Beige Mice. (23rd January 2014) Authors: Bombardieri, M.; Rocher, V.; Mittereder, N.; Carlesso, G.; Herbst, R.; Sleeman, M.; Pitzalis, C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗